# SELF-REVIEW-L7-002

**Outcome:** `PASS — internally hardened and reproduced`  
**Not:** external verification · certification · LIVE  
**Protocol:** REVIEW_PROTOCOL.md + Phase 10.1 hardening suites  
**Date:** 2026-09-01

Does **not** replace SELF-REVIEW-L7-001 (historical). Additive record only.

---

## 1. Frozen artifact integrity

| Artifact | SHA-256 |
|----------|---------|
| ART-L7-REPLAY-001 | `eb32c22799723c8676705f739314d0b917cc63c6c114aa3b2633063d3246b7b0` |
| ART-L7-REJECT-001 | `e743cc78adeeb7a20d59eb00b073b3db7bf4bba38535c2d8c61f697e040d2b89` |
| ART-L7-PARITY-001 | `bd9f0257775211b858a8ac87a585a4a04801117b50b2b0646cb062f99617a9dd` |
| ART-L7-PARITY-002 | `156aaaab9cdc550707d7ae2ba553a9d421b96bd8c5c69d8819cd65d1c30e298a` |

Matches SELF-REVIEW-L7-001 baselines. Mutation suite reported `originalsIntact: true`.

## 2. Node / Python / Go verification

Both capsules: **PASS** on all three implementations (re-confirmed in Phase 10.1 workspace).

## 3. Three-way parity

Exact hash agreement preserved (PARITY-002 remains valid historical report).

## 4. C1–C7 challenges

`challenge-art-l7.mjs` — EXIT 0 (prior foundation; still applicable).

## 5. Mutation suite

`mutation-art-l7.mjs` — **16/16 PASS**, originals intact.

Includes controls (M15/M16) expected to VERIFY_PASS and adversarial mutations expected to THROW or VERIFY_FAIL.

## 6. Canonicalization edge cases

`canon-edge-art-l7.mjs` — **14/14 PASS** under documented profile.

Unspecified for capsules (explicitly labeled, not invented):

- non-finite numbers
- scientific exponent forms beyond capsule usage

Observed JS behaviour documented: `-0` → `0`.

## 7. Verifier independence

See `INDEPENDENT_IMPLEMENTATION_AUDIT.md` — **PASS** (no cross-impl or UI dependency).

## 8. Evidence boundary

See `EVIDENCE_BOUNDARY_L7.md` — offline verification possible; **repository/supply-chain trust remains**.

## 9. Reject-path scope

See `REJECT_PATH_SCOPE_L7.md` — pure rejection **VERIFIED** for capsule; production ledger recording **UNAVAILABLE**.

## 10. Remaining weaknesses

1. Level 2 external human review still **OPEN**.
2. Mutation catalog is larger than C1–C7 but still finite — not complete attack coverage.
3. Mutation runner embeds a Node pure reducer (not a fourth independent impl).
4. No third-party archive / detached signature of the freeze set yet.
5. Canonicalization of exotic floats / non-ASCII keys remains lightly exercised.

## Final result

```text
PASS — internally hardened and reproduced
```

**Level 2 (human external review): remains OPEN.**
